Zimmer Biomet reports more than $2 billion in second-quarter net sales
Zimmer Biomet Holdings Inc. reported net sales of $2.027 billion for the second quarter of 2021, according to reported financial results.
The second-quarter net sales showed a 65.3% increase from the prior year period and a 60.7% increase on a constant currency basis. Additionally, second-quarter 2021 sales increased 1.9% compared with the second quarter in 2019, before the COVID-19 pandemic.
Zimmer Biomet earned a net of $141.9 million in the second quarter of 2021. The company reported that diluted earnings per share were $0.76 and, when adjusted, diluted earnings per share were $1.90.
“Our performance in the second quarter improved meaningfully from the first-quarter 2021 across all regions and product categories as recovery from the global pandemic continued to take hold. While we anticipate some ongoing COVID-19 pressure, we expect continued improvement in procedure volume recovery through the second half of 2021,” Bryan Hanson, chair, president and CEO of Zimmer Biomet, said in a press release.
Read more about